PEDIATRIC OPTIC PATHWAY GLIOMA: DIENCEPHALIC SYNDROME

QR Code

PEDIATRIC OPTIC PATHWAY GLIOMA: DIENCEPHALIC SYNDROME

Diencephalic cachexia (DC ) is a metabolic disorder characterized by a decrease in body weight. DC usually occurs in the presence of glioma brain tumors extended into the optic pathway. These tumors are very aggressive and have poor prognosis.Objective: to analyze the clinical course of optic pathwa...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. F. Valiakhmetova, N. A. Mazerkina, L. I. Papusha, O. I. Bydanov, E. M. Tarasova, O. A. Medvedeva, N. K. Serova, L. A. Lazareva, L. V. Shishkina, Yu. Yu. Trunin, G. A. Novichkova, S. K. Gorelyshev, A. I. Karachunsky
Format:	Article
Language:	Russian
Published:	Russian Academy of Sciences, Tomsk National Research Medical Center 2021-03-01
Series:	Сибирский онкологический журнал
Subjects:	optic pathway gliomas low grade gliomas children diencephalic syndrome
Online Access:	https://www.siboncoj.ru/jour/article/view/1689
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Expression of toll-like receptors and inflammatory mediators in primary human glioma cells (low- and high-grade) compared to primary cells from epileptic human brain
by: Negin Masoomabadi, et al.
Published: (2025-09-01)

Diffuse midline glioma of the brainstem: genetic features, complications and treatment prospects
by: A. M. Kryanev, et al.
Published: (2024-06-01)

SEARCH for NEW microRNA MARKERS FOR DIFFERENTIAL DIAGNOSIS OF different grade CEREBRAL GLIOMAS
by: E. V. Stupak, et al.
Published: (2019-02-01)

Promises of targeted therapy for low grade gliomas in children
by: E. F. Valiakhmetova, et al.
Published: (2019-07-01)

Immunology and prospects of immunotherapy against malignant gliomas: humoral immunity
by: S. A. Kulyova, et al.
Published: (2021-12-01)

Complexities in Pediatric Oncology: A Case of Misdiagnosed High‐Grade Glioma Transforming Into Fibrosarcoma
by: Bijita Aryal, et al.
Published: (2025-07-01)

Natural Compounds That Target Glioma Stem Cells
by: Mariia Yaroshenko, et al.
Published: (2025-06-01)

Temozolomide-based radio-chemotherapy for newly diagnosed pediatric high-grade gliomas (HIT-HGG-2007): A prospective, multicenter, single-arm, phase II trial
by: Michael Karremann, et al.
Published: (2025-12-01)

Magnetic Resonance Imaging Radiomics-Driven Artificial Neural Network Model for Advanced Glioma Grading Assessment
by: Yan Qin, et al.
Published: (2025-06-01)

ONCOLYTIC VIROTHERAPY IN GLIOBLASTOMA TREATMENT: PROGRESS AND CHALLENGES IN CLINICAL RESEARCH (LITERATURE REVIEW)
by: O. I. Kit, et al.
Published: (2020-12-01)

DIFFERENTIAL DIAGNOSIS OF BRAIN GLIOMAS BY POSITRON EMISSION TOMOGRAPHY USING VARIOUS RADIOPHARMACEUTICALS
by: N. A. Kostenikov, et al.
Published: (2016-02-01)

Fluorescent diagnostics with chlorin e6 in surgery of low-grade glioma
by: A. Yu. Rynda, et al.
Published: (2022-02-01)

Molecular Biomarkers of Glioma
by: Punsasi Rajakaruna, et al.
Published: (2025-05-01)

Prediction model for the selection of patients with glioma to proton therapy
by: Jesper Folsted Kallehauge, et al.
Published: (2025-07-01)

INHIBITORY NEUROTRANSMITTERS AND THEIR INFLUENCE ON TUMOR IN PATIENTS WITH GLIOMAS
by: A. V. Kartashev, et al.
Published: (2016-02-01)

In silico analysis reveals distinct changes in markers of epithelial to mesenchymal transition in glioma subtypes
by: Nives Pećina-Šlaus, et al.
Published: (2025-07-01)

The mechanism of development of post-traumatic gliomas
by: I. F. Gareev, et al.
Published: (2021-12-01)

CURRENT APPROACHES TO CHEMORADIOTHERAPY FOR MALIGNANT GLIOMAS
by: Ye. L. Choinzonov, et al.
Published: (2014-06-01)

Integrated 4D label-free proteome and SUMOylated proteome in glioma uncover novel pathological mechanisms and pave the way for precision therapy
by: Jiazheng Wang, et al.
Published: (2025-08-01)

Objectivic estimation metods of life quality at the patients with malignant brain glioma in dynamics of their complex treatment
by: I. V. Balayzin, et al.
Published: (2011-04-01)

Prognostic Value of SERPINA1 as a Biomarker for Poor Survival of Gliomas
by: Nai-Jui Cheng, et al.
Published: (2025-07-01)

Angiocentric glioma: clinical, pathomorphological and neuroradiological features of a rare epileptogenic tumor (a review and clinical case)
by: V. S. Khalilov, et al.
Published: (2024-11-01)

DNA repair in cancer stem cells as a factor for glioma resistance to radiotherapy
by: Yu. S. Makusheva, et al.
Published: (2015-07-01)

Executive dysfunctions in patients with low-grade gliomas in the supplementary motor area: a neuropsychological perspective
by: Aleksandra Bala, et al.
Published: (2025-07-01)

Robust prediction of glioma prognosis by hypoxia-induced ferroptosis genes: VEGFA-XBP1 co-expression for salvage therapy
by: Zhou Liwei, et al.
Published: (2025-12-01)

Extraneural metastases of a cerebral glioma in a child: case report with literature review
by: O. S. Regentova, et al.
Published: (2024-09-01)

Integrative analysis of polyamine metabolism-related genes in gliomas: implications for prognosis and therapy
by: Yujia Zhao, et al.
Published: (2025-07-01)

Value of MRI radiomics based on intratumoral and peritumoral heterogeneity in predicting spatial patterns of locally recurrent high-grade gliomas
by: WANG Hanwei, et al.
Published: (2025-07-01)

Analysis of epidemiology and nomogram construction for prediction and clinical decision-making in gliomas
by: Yuxin Zhao, et al.
Published: (2025-08-01)

Super-resolution microscopy reveals glioma cell footprints and exosome deposits
by: Stefania Petrini, et al.
Published: (2025-12-01)

Comparative efficacy of glioma treatment strategies: an umbrella review of meta-analyses
by: Erming Yang, et al.
Published: (2025-12-01)

Network Analysis of Multidimensional Symptoms and Inflammatory Biomarkers in Chinese Patients with Glioma
by: Li H, et al.
Published: (2025-05-01)

Global research status, hotspots and prospects of ferroptosis in glioma: a scientometric analysis
by: Jing Liu, et al.
Published: (2025-08-01)

Epileptic syndrome in the clinical picture of the diseaseand the level of antibodies to GluR1 subunit of AMPA glutamate receptors in the patients with gliomas in the cerebral hemispheres of a brain
by: V. N. Ochkolyas, et al.
Published: (2013-12-01)

Radiomics and Radiogenomics in Differentiating Progression, Pseudoprogression, and Radiation Necrosis in Gliomas
by: Sohil Reddy, et al.
Published: (2025-07-01)

Highly expressed of SERPINA3 indicated poor prognosis and involved in immune suppression in glioma
by: Qing Yuan, et al.
Published: (2021-12-01)

OUTCOMES OF 5-ALA FLIORESCECE-GUIDED SURGERY FOR HIGH GRADE G
by: V. A. Byvaltsev, et al.
Published: (2018-05-01)

SIGNIFICANCE OF PROGNOSTIC FACTORS IN THE MULTIMODALITY TREATMENT OF SUPRATENTORIAL INFILTRATIVE LOW-GRADE GLIOMAS
by: V. A. Solodkiy, et al.
Published: (2016-07-01)

Vaccine therapies for glioma: clinical frontiers and potential breakthrough
by: Ying Xing, et al.
Published: (2025-06-01)

The Prognostic Significance of TMSB4X in Glioma Patients
by: Li S, et al.
Published: (2025-06-01)